"Ottorino Rossi" Award 2000. New targets for therapy in Parkinson's disease: pathogenesis and pathophysiology.
Greenamyre
J T
JT
Department of Neurology, Emory University School of Medicine, Atlanta, GA 30322, USA.
D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine / Q000494:pharmacology; D000818:Animals; D000978:Antiparkinson Agents / Q000494:pharmacology; D001363:Awards and Prizes; D001667:Binding, Competitive / Q000502:physiology; D001921:Brain / Q000503:physiopathology; D003342:Corpus Striatum / Q000378:metabolism / Q000503:physiopathology; D004298:Dopamine / Q000378:metabolism; D015259:Dopamine Agents / Q000494:pharmacology; D015536:Down-Regulation / Q000187:drug effects; D006801:Humans; D023421:Models, Animal; D009474:Neurons / Q000378:metabolism; D010300:Parkinson Disease / Q000378:metabolism / Q000503:physiopathology* / Q000628:therapy*; D011699:Putamen / Q000378:metabolism / Q000503:physiopathology; D018091:Receptors, AMPA / Q000187:drug effects / Q000502:physiology; D016194:Receptors, N-Methyl-D-Aspartate / Q000187:drug effects / Q000502:physiology; D013378:Substantia Nigra / Q000378:metabolism / Q000503:physiopathology
D000978:Antiparkinson Agents; D015259:Dopamine Agents; D018091:Receptors, AMPA; D016194:Receptors, N-Methyl-D-Aspartate; D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D004298:Dopamine